arrow
D

David Goldblatt

university college london
H指数:80
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Determining the dose-response relationship for pneumococcal conjugate vaccines: a nested analysis of the fractional dose PCV trial

确定肺炎球菌结合疫苗的剂量-反应关系:一项PCV分数剂量试验的嵌套分析

Vaccine
IF3.5
2026-01-060
OAAI
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

实现疫苗开发、许可和使用的保护相关潜力: 简短摘要

2024-04-298
OAAI
Clonal Expansion of a Streptococcus pneumoniae Serotype 3 Capsule Variant Sequence Type 700 With Enhanced Vaccine Escape Potential After 13-Valent Pneumococcal Conjugate Vaccine Introduction

引入13价肺炎球菌结合疫苗后,具有增强的疫苗逃逸潜力的肺炎链球菌血清型3荚膜变异序列700型的克隆扩增

2024-03-262
OAAI
Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveys

肯尼亚基利菲的人群对肺炎球菌血清型的免疫力,在引入PCV10之前和之后6年进行追赶运动: 横断面血清调查的观察性研究

2023-11-013
OAAI
Socioeconomic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort Study

英国医院医护人员SARS-CoV-2血清阳性的社会经济和人口危险因素: 一项前瞻性队列研究

2023-08-301
OAAI
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing

通过抗体检测预测免疫功能低下人群的新型冠状病毒肺炎感染风险

LANCET
IF88.5
2023-07-015
OAAI
Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2+1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active- controlled, randomised, phase 3 trial

冈比亚健康婴儿接种10价肺炎球菌结合疫苗2 1方案的免疫原性和安全性: 一项单中心、双盲、主动对照、随机3期试验

2023-05-014
OAAI
When to update COVID-19 vaccine composition

何时更新新型冠状病毒肺炎疫苗组合物

2023-02-2013
OA
Novel Multilocus Sequence Typing and Global Sequence Clustering Schemes for Characterizing the Population Diversity of Streptococcus mitis

用于表征链球菌种群多样性的新型多位点序列分型和全局序列聚类方案

2023-01-262
OAAI
Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3+0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population- level, serosurveillance study

马拉维布兰太尔5岁以下儿童在生命的第一年内使用3 0时间表,由13价肺炎球菌结合疫苗诱导的抗体水平下降: 一项观察性,人群水平,血清监测研究

2022-12-0126
OAAI
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children

SARS-CoV-2 mRNA疫苗接种在儿童中引发强大的抗体反应

2022-11-2325
OAAI